DUBLIN--(BUSINESS WIRE)--The "US Scleroderma Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering. United States Scleroderma Market and Competitive ...

DUBLIN--(BUSINESS WIRE)--The "Global Scleroderma Therapeutics Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The value of the global scleroderma ...

The "US Scleroderma Market and Competitive Landscape – 2021" report has been added to ResearchAndMarkets.com’s offering. US Scleroderma Market and Competitive Landscape Highlights – 2021, provides ...

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

Suggested Citation: "4 Scleroderma." National Academies of Sciences, Engineering, and Medicine. 2022. Selected Immune Disorders and Disability. Washington, DC: The National Academies Press. doi: ...

When Dee Burlile was diagnosed with scleroderma in 2016, she didn’t know what it was or how to treat it. She quickly found out that she wasn’t alone. Scleroderma is a rare autoimmune condition that ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Methotrexate and mycophenolate mofetil similarly ...

Most people with scleroderma have autoantibodies. Several scleroderma-specific antibodies have been identified. These can help with diagnosis and give insight into the type of disease you may ...

The University of Michigan John Varga Lab, in collaboration with the Mayo Clinic and Northwestern researchers, published an article last year suggesting that a heavy-chain monoclonal antibody, Ab68, ...

The agency has approved nintedanib (Ofev) to slow the rate of pulmonary function decline in adult patients with interstitial lung disease associated with systemic sclerosis or scleroderma. The FDA has ...